Content about Supplier News

January 20, 2012

According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition. 


According to the American Diabetes Association’s latest figures, 79 million Americans have prediabetes, but only 1-out-of-10 knows it. That suggests a terrific upside in the market of diabetes-testing supplies and diabetes-supportive products as more of those Americans become aware of their condition. 


January 20, 2012

Bold brows are hot, as evidenced by the beauty looks at spring 2012 Fashion Week and the sales data at retail.

NEW YORK — Bold brows are hot, as evidenced by the beauty looks at spring 2012 Fashion Week and the sales data at retail. Looking to spring 2012, Maybelline New York has introduced its new Master Shape Brow pencil. The wax pencil features subtle color pigments for a natural look, and the groomer brush adds the finishing touch. It comes in blonde, soft brown, deep brown and auburn, and has a suggested retail price of $7.99.


Sales of eyebrow makeup at food, drug and mass (excluding Walmart) rose 5.9% in the 52 weeks ended Nov. 27, according to SymphonyIRI Group.

January 20, 2012

An Apple a day also may help keep the doctor away. iHealth Lab is expanding its offerings that can dock with Apple’s family of products, namely the iPhone, iPod and iPad.

NEW YORK — An Apple a day also may help keep the doctor away. iHealth Lab is expanding its offerings that can dock with Apple’s family of products, namely the iPhone, iPod and iPad. The company earlier this year launched its iHealth BP3 blood-pressure monitoring system and added its iHealth Digital Scale to its brand mix last October. Technophiles were exposed to the new products thanks to distribution through Best Buy and merchandising in Walmart’s electronics section through the holidays. 


January 20, 2012

Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.

PRINCETON, N.J. — Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.

Bristol made the donation to the HealthWell Foundation, which provides financial assistance to eligible people for covering co-insurance, co-payments, healthcare premiums and deductibles for certain treatments. The drug maker's donation is targeted toward underinsured cancer patients.

January 20, 2012

It has become a perennial issue, and one that is likely to crop up at least once this year: patent settlements.


It has become a perennial issue, and one that is likely to crop up at least once this year: patent settlements.


January 20, 2012

For all the talk about generic drugs and their potential to save piles of money for the country’s healthcare system, it’s going to be a while before many of them actually reach consumers because of the Food and Drug Administration’s huge backlog of generic drug regulatory approval applications.


For all the talk about generic drugs and their potential to save piles of money for the country’s healthcare system, it’s going to be a while before many of them actually reach consumers because of the Food and Drug Administration’s huge backlog of generic drug regulatory approval applications.


January 20, 2012

With the patent cliff and subsequent innovation drought moving closer, generic drug makers are looking to move up the value chain and pursue new sources of revenue, and of all the piles of pay dirt out there, biosimilars represent one of the closest things to an El Dorado, though regulations won’t take their final form for a while.


With the patent cliff and subsequent innovation drought moving closer, generic drug makers are looking to move up the value chain and pursue new sources of revenue, and of all the piles of pay dirt out there, biosimilars represent one of the closest things to an El Dorado, though regulations won’t take their final form for a while.


January 20, 2012

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

January 20, 2012

Huggies has introduced its new branded YouTube channel, which is designed to give parents the opportunity to show off their active babies' unique moves.

DALLAS — Huggies has introduced its new branded YouTube channel, which is designed to give parents the opportunity to show off their active babies' unique moves.

January 20, 2012

New products and innovation helped drive sales of depilatories. According to SymphonyIRI Group, sales of depilatories rose more than 15% to $23.4 million for the most recent 12 weeks ended Nov. 27 at food, drug and mass (excluding Walmart).


New products and innovation helped drive sales of depilatories. According to SymphonyIRI Group, sales of depilatories rose more than 15% to $23.4 million for the most recent 12 weeks ended Nov. 27 at food, drug and mass (excluding Walmart).


Olay recently entered the segment with its new Olay Smooth Finish Facial Hair Removal Duo, a two-step system to remove unwanted facial hair. Earlier in 2011, Veet launched its Ready-to-Use Hair Removal Wax Strips For Face & Body and also reformulated its Veet Fast Acting creams for normal and sensitive skin.

 

 

January 20, 2012

Record-breaking attendance and four panel discussions on such topics as specialty pharmacy and diabetes set the stage for the 13th annual Drug Store News Industry Issues Summit held on Nov. 29 in New York City.

Record-breaking attendance and four panel discussions on such topics as specialty pharmacy and diabetes set the stage for the 13th annual Drug Store News Industry Issues Summit held on Nov. 29 in New York City. This year’s event attracted more than 30 retailers and 200 industry suppliers. 


January 20, 2012

SymphonyIRI Group on Thursday identified the executives sitting on its new board of directors, including the naming of Lawrence Benjamin as chairman.

CHICAGO — SymphonyIRI Group on Thursday identified the executives sitting on its new board of directors, including the naming of Lawrence Benjamin as chairman.

A 25-year veteran, Benjamin most recently held several executive positions at Royal Ahold, including CEO of U.S. foodservice, COO of Ahold's U.S. retail businesses, EVP and a seat on the company's global board. Previously, he was CEO for NutraSweet and president of the frozen meals division of Kraft. Benjamin currently is a senior adviser at New Mountain Capital.

January 20, 2012

If the patent cliff were a sports team, Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin) would be its mascot.

If the patent cliff were a sports team, Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin) would be its mascot. Because it’s the top-selling drug, well, ever — with 2010 sales well in excess of $7 billion in the United States alone — Lipitor’s loss of patent protection on Nov. 30, 2011, didn’t start or end the patent cliff but in many ways symbolized it.


January 20, 2012

Users of Mscripts' mobile pharmacy application platform will have a host of new features to make managing prescriptions and shopping easier, according to a presentation the company gave Friday at the Health Innovation Summit.

SAN FRANCISCO — Users of Mscripts' mobile pharmacy application platform will have a host of new features to make managing prescriptions and shopping easier, according to a presentation the company gave Friday at the Health Innovation Summit.

January 20, 2012

Procter & Gamble Beauty has partnered with Alicia Sacramone, Beijing 2008 Olympic Games silver medalist, who will serve as an ambassador for P&G beauty brands, including CoverGirl, Olay, Pantene and Secret.

CINCINNATI — Procter & Gamble Beauty has partnered with Alicia Sacramone, Beijing 2008 Olympic Games silver medalist, who will serve as an ambassador for P&G beauty brands, including CoverGirl, Olay, Pantene and Secret.

Sacramone’s involvement is in addition to P&G’s partnership with USA Gymnastics and its global marketing partnership with the International Olympic Committee in support of the Olympic Movement, which will reach through the next five Olympic Games from London 2012 through the 2020 Olympic Games.

January 20, 2012

Walgreens’ contract with Express Scripts expired, and millions of Walgreens customers covered by ESI were forced to either move their pharmacy business or come up with some other way to stick with Walgreens. Drug Store News interviewed Walgreens president and CEO Greg Wasson on what the company is doing to hold on to those customers and how it is appealing to payers.

On Jan. 1, Walgreens’ contract with Express Scripts expired, and millions of Walgreens customers covered by ESI were forced to either move their pharmacy business or come up with some other way to stick with Walgreens. Drug Store News interviewed Walgreens president and CEO Greg Wasson on what the company is doing to hold on to those customers and how it is appealing to payers.

January 20, 2012

Celebrity Denise Richards announced on her blog on Jan. 2 that she has teamed up with stylist Cristophe to create her own hair care line.

SUPPLIER NEWS — Celebrity Denise Richards announced on her blog on Jan. 2 that she has teamed up with stylist Cristophe to create her own hair care line. The Denise Richards Volume Extend hair care line consists of shampoo, conditioner and three styling aids. The line is launching in late January.


January 20, 2012

Slim Fast and The Biggest Loser diets were identified as among the leading diets by U.S. News & World Report earlier this month.

Slim Fast and The Biggest Loser diets were identified as among the leading diets by U.S. News & World Report earlier this month. The ranking may reinvigorate sales across the Slim Fast franchise, which dropped to No. 11 across weight control liquids sold through food, drug and mass (excluding Walmart) for the 12 weeks ended Nov. 27 with $4.8 million in sales, according to SymphonyIRI Group. And while not necessarily associated with the Biggest Loser diet, Biggest Loser trainer Bob Harper’s signature diet aid tablet is on the rise with $1 million in sales, ranking No.

January 20, 2012

Flawless, luminous skin is in, and with spring about to spring, you can bet that beauty mavens will continue their search for face makeup that helps their skin glow.


Flawless, luminous skin is in, and with spring about to spring, you can bet that beauty mavens will continue their search for face makeup that helps their skin glow.


Sales of foundation at food, drug and mass (excluding Walmart) 
rose more than 4% to $543.7 million for the 52 weeks ended Nov. 27, according to SymphonyIRI Group. During that same period, sales of concealer climbed nearly 9.6% to $118.9 million, and sales of blush rose 2.4% to $107.6 million. 


January 19, 2012

The Food and Drug Administration has declined to approve a drug for Type 2 diabetes made by Bristol-Myers Squibb and AstraZeneca, saying it needs additional clinical data, the companies said Thursday.

PRINCETON, N.J. — The Food and Drug Administration has declined to approve a drug for Type 2 diabetes made by Bristol-Myers Squibb and AstraZeneca, saying it needs additional clinical data, the companies said Thursday.

January 19, 2012

Dannon is showcasing its Greek yogurt line with a new advertisement that will debut during Super Bowl XLVI.

WHITE PLAINS, N.Y. — Dannon is showcasing its Greek yogurt line with a new advertisement that will debut during Super Bowl XLVI.

The company said its new Dannon Oikos Greek yogurt ad is part of a fully-integrated marketing campaign designed to emphasize its better-for-you position in the market. The ad will feature actor John Stamos, who appeared in a Dannon Oikos Greek yogurt last August.

January 19, 2012

The Food and Drug Administration has approved a lower-dose formulation of a drug made by Gilead Sciences for treating HIV in children, the company said.

FOSTER CITY, Calif. — The Food and Drug Administration has approved a lower-dose formulation of a drug made by Gilead Sciences for treating HIV in children, the company said.

Gilead announced the FDA approval of Viread (tenofovir disoproxil fumarate) in the 150-mg, 200-mg and 250-mg strengths combined with other antiretroviral drugs in patients ages 6 to 12 years while also approving an oral powder formulation for children ages 2 to 5 years. The agency approved the drug in the 300-mg strength for adults in 2001 and for patients ages 12 to 17 years in 2010.

January 19, 2012

After weeks of speculation, Kodak and its U.S. subsidiaries officially filed voluntary petitions for Chapter 11 business reorganization.

ROCHESTER, N.Y. — After weeks of speculation, Kodak and its U.S. subsidiaries officially filed voluntary petitions for Chapter 11 business reorganization.

January 19, 2012

Drug maker Sandoz has started two late-stage clinical trials of biosimilar drugs for treating cancer patients undergoing chemotherapy, the company said Thursday, saying the studies were meant to support the drugs' eventual marketing in the United States.

HOLZKIRCHEN, Germany — Drug maker Sandoz has started two late-stage clinical trials of biosimilar drugs for treating cancer patients undergoing chemotherapy, the company said Thursday, saying the studies were meant to support the drugs' eventual marketing in the United States.

January 19, 2012

The wholesale arm of specialty pharmacy The Apothecary Shops has received distribution rights to a drug for treating age-related macular degeneration, the company said Thursday.

PHOENIX — The wholesale arm of specialty pharmacy The Apothecary Shops has received distribution rights to a drug for treating age-related macular degeneration, the company said Thursday.

Apothecary Shops Wholesale has begun distributing Regeneron Pharmaceuticals' Eylea (aflibercept) to physicians and patients. The drug is used to treat neovascular or "wet" AMD. The "wet" form usually leads to more serious vision loss.